Involvement of human PECAM-1 in angiogenesis and in vitro endothelial cell migration
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Platelet endothelial cell adhesion molecule (PECAM)-1 has been implicated in angiogenesis, but a number of issues remain unsettled, including the independent involvement of human PECAM-1 (huPECAM-1) in tumor angiogenesis and the mechanisms of its participation in vessel formation. We report for tumors grown in human skin transplanted on severe combined immunodeficiency mice that antibodies against huPECAM-1 (without simultaneous treatment with anti-VE-cadherin antibody) decreased the density of human, but not murine, vessels associated with the tumors. Anti-huPECAM-1 antibody also inhibited tube formation by human umbilical vein endothelial cells (HUVEC) and the migration of HUVEC through Matrigel-coated filters or during the repair of wounded cell monolayers. The involvement of huPECAM-1 in these processes was confirmed by the finding that expression of huPECAM-1 in cellular transfectants induced tube formation and enhanced cell motility. These data provide evidence of a role for PECAM-1 in human tumor angiogenesis (independent of VE-cadherin) and suggest that during angiogenesis PECAM-1 participates in adhesive and/or signaling phenomena required for the motility of endothelial cells and/or their subsequent organization into vascular tubes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070 · cited 2×
“In terms of EC, angiogenesis can be viewed as a process in which these cells sever their initial cell-cell contacts, proliferate, and migrate into the perivascular matrix where they reestablish their cell-cell associations to form new patent vascular channels (11).”
Background
Cited by
Endothelial functions of platelet/endothelial cell adhesion molecule-1 (CD31)
Lertkiatmongkol, P., Liao, D., Mei, H., Hu, Y., & Newman, P. J. (2016) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000239 · Cited by 626
PECAM-1: regulator of endothelial junctional integrity
Privratsky, J. R., & Newman, P. J. (2014) · Cell and Tissue Research · doi:10.1007/s00441-013-1779-3 · Cited by 366
Eisenhofer, G., Huynh, T.-T., Pacak, K., Brouwers, F. M., Walther, M. M., Linehan, W. M., Munson, P. J., Mannelli, M., Goldstein, D. S., & Elkahloun, A. G. (2004) · Endocrine-Related Cancer · doi:10.1677/erc.1.00838 · Cited by 207
“…(Lelievre et al. 2000, Wary et al. 2003), stanniocalcin 1 (Liu et al. 2003), platelet endothelial cell adhesion molecule-1 (Bautch et al. 2000, Cao et al. 2002), vascular cell adhesion molecule-1 (Kim et al. 2001), phosphatidic acid phosphatase 2b (Humtsoe et al. 2003), cyclo-oxygenases 1…”
Bentz, G. L., Jarquin-Pardo, M., Chan, G., Smith, M. S., Sinzger, C., & Yurochko, A. D. (2006) · Journal of Virology · doi:10.1128/jvi.01016-06 · Cited by 130
Carreau, A., Kieda, C., & Grillon, C. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.08.011 · Cited by 88
“[30], demonstrating that through PECAM-1/ CD31 transfection, REN cells acquire the capacity tomigrate and form tubular structures onMatrigelTM.”
Background
Metadata
- Authors
- Cao, G., O'Brien, C. D., Zhou, Z., Sanders, S. M., Greenbaum, J. N., Makrigiannakis, A., & DeLisser, H. M.
- Venue
- American Journal of Physiology-Cell Physiology
- Publisher
- American Physiological Society
- Published
- 2002-05-01
- Volume
- 282
- Issue
- 5
- Pages
- C1181-C1190
- ISSN
- 0363-6143 (ISSN-L)
- 1522-1563
- OpenAlex
- W2099961094
- Cited by
- 215
- References
- 1
- FWCI
- 3.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.